Aurora Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History

Aurora Investment Counsel’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-662	Closed	-$323K	–	125
2020 Q1	$323K	Sell	662 -2,354	-78%	-$971K	0.36%	108
2019 Q4	$1.13M	Sell	3,016 -1,957	-39%	-$658K	0.85%	63
2019 Q3	$1.38M	Buy	4,973 +159	+3%	+$47K	0.67%	98
2019 Q2	$1.47M	Buy	4,814 +1,423	+42%	+$474K	0.7%	86
2019 Q1	$1.39M	Buy	+3,391	New	+$1.4M	0.69%	90
2014 Q4	$1.82M	Sell	4,436 -2,054	-32%	-$808K	1.12%	47
2014 Q3	$2.34M	Sell	6,490 -110	-2%	-$36.9K	1.54%	7
2014 Q2	$1.86M	Buy	6,600 +162	+3%	+$48K	1.17%	37
2014 Q1	$1.93M	Buy	6,438 +158	+3%	+$48.7K	1.24%	27
2013 Q4	$1.73M	Buy	+6,280	New	+$1.81M	1.14%	44

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Aurora Investment Counsel's REGN Position: Q2 2020 in Review

Aurora Investment Counsel sold out of Regeneron Pharmaceuticals (REGN) in Q2 2020, closing a stake of 662 shares — an estimated $323K sold.

Aurora Investment Counsel first reported a position in REGN in Q4 2013 and held it in 10 quarters. The position peaked at $2.34M in Q3 2014. 932 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

Aurora Investment Counsel reported no remaining Regeneron Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Aurora Investment Counsel sold 662 Regeneron Pharmaceuticals shares in Q2 2020, an estimated $323K.
Aurora Investment Counsel first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 10 quarters.
Aurora Investment Counsel's Regeneron Pharmaceuticals position peaked at $2.34M in Q3 2014.
932 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on Aurora Investment Counsel's 13F filing for Q2 2020, filed 24 Aug 2020.